JO SANDBU CLINICAL RESEARCH AS

0671 OSLO

Finances

Return on Equity

−18,43 %

Current Ratio

10,15

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	151 000	474 000	164 000	211 000
Net Income	−265 000	118 000	−199 000	−198 000
Total Assets	1 594 000	1 770 000	1 626 000	1 814 000
Total Equity	1 438 000	1 703 000	1 586 000	1 784 000

Income (NOK)	2022	2021	2020	2019
Revenue	151 000	474 000	164 000	211 000
Expenditure	417 000	352 000	362 000	408 000
Operating Profit	−265 000	122 000	−198 000	−197 000
Financial Income	1 000	2 000	1 000	0
Financial Costs	1 000	6 000	2 000	1 000
Financial Balance	0	−4 000	−1 000	−1 000
Earnings Before Tax	−265 000	118 000	−199 000	−198 000
Tax	0	0	0	0
Net Income	−265 000	118 000	−199 000	−198 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	10 000	15 000	19 000	23 000
Total Current Assets	1 584 000	1 756 000	1 608 000	1 791 000
Total Assets	1 594 000	1 770 000	1 626 000	1 814 000
Total Retained Equity	1 338 000	1 603 000	1 486 000	1 684 000
Total Equity	1 438 000	1 703 000	1 586 000	1 784 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	156 000	67 000	41 000	30 000
Total Equity and Debt	1 594 000	1 770 000	1 626 000	1 814 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	151 000	474 000	164 000	211 000
Other Income	0	0	0	0
Revenue	151 000	474 000	164 000	211 000
Cost of Goods Sold	0	0	0	0
Salary Costs	291 000	288 000	282 000	296 000
Depreciation	4 000	4 000	4 000	0
Impairment	0	0	0	0
Expenditure	417 000	352 000	362 000	408 000
Operating Profit	−265 000	122 000	−198 000	−197 000
Financial Income	1 000	2 000	1 000	0
Financial Costs	1 000	6 000	2 000	1 000
Financial Balance	0	−4 000	−1 000	−1 000
Dividends	0	0	0	0
Net Income	−265 000	118 000	−199 000	−198 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	10 000	15 000	19 000	23 000
Fixtures	0	0	0	0
Total Tangible Assets	10 000	15 000	19 000	23 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	10 000	15 000	19 000	23 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	1 284 000	1 492 000	1 326 000	1 538 000
Total Current Assets	1 584 000	1 756 000	1 608 000	1 791 000
Total Assets	1 594 000	1 770 000	1 626 000	1 814 000
Total Equity	1 438 000	1 703 000	1 586 000	1 784 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	29 000	10 000	27 000	11 000
Unpaid Taxes	127 000	60 000	17 000	22 000
Dividends	0	0	0	0
Other Current Debt	0	−3 000	−3 000	−3 000
Total Current Debt	156 000	67 000	41 000	30 000
Total Equity and Debt	1 594 000	1 770 000	1 626 000	1 814 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−18,43 %	6,93 %	−12,55 %	−11,1 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−175,5 %	25,74 %	−120,73 %	−93,36 %
Current Ratio	10,15	26,21	39,22	59,7
Quick Ratio	10,15	26,21	39,22	59,7
Equity Ratio	0,9	0,96	0,98	0,98
Gross Profit Margin	100 %	100 %	100 %	100 %